Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01100268 · ClinicalTrials.gov registry record · Phase 2

Enhancing Attention in Adults With Compulsive Hoarding

A Phase 2 study of Hoarding Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
Phase 2
Development phase
4
Enrollment target
2
Study locations

NCT01100268: Completed Phase 2 study of Hoarding Disorder, sponsored by New York State Psychiatric Institute.

NCT01100268 is a Phase 2 study of Hoarding Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 4 participants, below the 39-participant average among 4 other Hoarding Disorder trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01100268, a Phase 2 study of Hoarding Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
Phase 2
Development phase
4 participants
Enrollment target
2
Study locations

Study Summary

Available data suggest that compulsive hoarders have cognitive deficits, particularly with sustaining attention that might contribute their hoarding symptoms.

Primary Outcome

Patients given Attention Deficit Hyperactivity Disorder Symptom Scale (ADHDSS), a measure of the features of Attention Deficit Hyperactivity Disorder including inattention, hyperactivity, and impulsivity. This scale has shown excellent reliability in prior studies of individuals with HD. For the ADHDSS the minimum units are 0 and Maximum units on the total scale are 54 (adult). The higher the number on the ADHDSS, the more severe the symptoms. Response was defined as at least a 30% reduction on

Conditions Studied

Interventions

  • DRUG Methylphenidate ER

Study Locations (2)

Connecticut

  • Institute of Living - Hartford

New York

  • New York State Psychiatric Insitute - New York

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2010-04
Est. Completion 2011-04
Phase Phase 2

What the finished NCT01100268 record still lists

NCT01100268 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 39-participant average among 4 other Hoarding Disorder trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Hoarding Disorder appearing as the primary indexed condition, and to 1 intervention - of which Methylphenidate ER is the first listed.

NCT01100268 reports a single indexed study location in Connecticut, New York.

Frequently Asked Questions

What is clinical trial NCT01100268 about?

NCT01100268 is a clinical study titled "Enhancing Attention in Adults With Compulsive Hoarding". Available data suggest that compulsive hoarders have cognitive deficits, particularly with sustaining attention that might contribute their hoarding symptoms.

What is the current status of trial NCT01100268?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2010-04. Estimated completion is 2011-04.

What conditions does trial NCT01100268 study?

This clinical trial studies the following conditions: Hoarding Disorder.

What interventions are being tested in trial NCT01100268?

The interventions under investigation include: Methylphenidate ER (DRUG).

Who is sponsoring clinical trial NCT01100268?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01100268 being conducted?

This trial has 2 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hoarding Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01100268, the US trial registry maintained by the National Library of Medicine. NCT01100268 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.